JP2025507292A5 - - Google Patents
Info
- Publication number
- JP2025507292A5 JP2025507292A5 JP2024546071A JP2024546071A JP2025507292A5 JP 2025507292 A5 JP2025507292 A5 JP 2025507292A5 JP 2024546071 A JP2024546071 A JP 2024546071A JP 2024546071 A JP2024546071 A JP 2024546071A JP 2025507292 A5 JP2025507292 A5 JP 2025507292A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heterocycloalkyl
- cycloalkyl
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305786P | 2022-02-02 | 2022-02-02 | |
| US63/305,786 | 2022-02-02 | ||
| PCT/US2023/061727 WO2023150535A1 (en) | 2022-02-02 | 2023-02-01 | Protein tyrosine phosphatase inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507292A JP2025507292A (ja) | 2025-03-18 |
| JP2025507292A5 true JP2025507292A5 (cg-RX-API-DMAC7.html) | 2026-02-09 |
Family
ID=87552989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546071A Pending JP2025507292A (ja) | 2022-02-02 | 2023-02-01 | プロテインチロシンホスファターゼ阻害剤およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250136564A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4472976A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025507292A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119137117A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128418A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202337459A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023150535A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL314650A (en) * | 2022-02-02 | 2024-09-01 | Nerio Therapeutics Inc | Protein tyrosine phosphatase inhibitors and uses thereof |
| WO2024243441A1 (en) | 2023-05-24 | 2024-11-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
| WO2025030008A1 (en) * | 2023-08-02 | 2025-02-06 | Nerio Therapeutics, Inc. | Protein tyrosine phosphatase inhibitor combinations |
| CN120004876B (zh) * | 2023-11-16 | 2026-02-06 | 英矽智能科技(上海)有限公司 | 蛋白酪氨酸磷酸酶抑制剂及其应用 |
| CN117343052B (zh) * | 2023-12-04 | 2024-02-06 | 英矽智能科技(上海)有限公司 | 蛋白酪氨酸磷酸酶抑制剂及其应用 |
| WO2026108900A1 (zh) * | 2024-11-20 | 2026-05-28 | 湖北生物医药产业技术研究院有限公司 | 作为蛋白质酪氨酸磷酸酶抑制剂的含苯并环类化合物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94724C2 (en) * | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| JP2016516004A (ja) * | 2013-02-22 | 2016-06-02 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病二環式化合物 |
| KR102983496B1 (ko) * | 2019-03-14 | 2026-06-29 | 칼리코 라이프 사이언시스 엘엘씨 | 단백질 티로신 포스파타제 억제제 및 이의 사용 방법 |
| EP4211122A1 (en) * | 2020-09-11 | 2023-07-19 | Calico Life Sciences LLC | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| EP4305030A4 (en) * | 2021-03-11 | 2025-05-21 | Kumquat Biosciences Inc. | HETEROCYCLES AND THEIR USES |
-
2023
- 2023-02-01 CN CN202380032050.5A patent/CN119137117A/zh active Pending
- 2023-02-01 EP EP23750344.6A patent/EP4472976A4/en active Pending
- 2023-02-01 JP JP2024546071A patent/JP2025507292A/ja active Pending
- 2023-02-01 AR ARP230100235A patent/AR128418A1/es unknown
- 2023-02-01 WO PCT/US2023/061727 patent/WO2023150535A1/en not_active Ceased
- 2023-02-01 US US18/834,761 patent/US20250136564A1/en active Pending
- 2023-02-01 TW TW112103529A patent/TW202337459A/zh unknown